A Pilot, Randomised, Blinded, Feasibility, Safety and Biochemical and Physiological Efficacy Study of Terlipressin vs. Placebo in Cardiac Surgery Patients with the Post-operative High Cardiac Output and Hypotension syndrome

Trial Profile

A Pilot, Randomised, Blinded, Feasibility, Safety and Biochemical and Physiological Efficacy Study of Terlipressin vs. Placebo in Cardiac Surgery Patients with the Post-operative High Cardiac Output and Hypotension syndrome

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Jan 2017

At a glance

  • Drugs Terlipressin (Primary)
  • Indications Acute heart failure; Heart disorders; Hypotension; Postoperative complications
  • Focus Therapeutic Use
  • Acronyms STEP
  • Most Recent Events

    • 04 Jan 2017 Planned initiation date changed from 1 Feb 2016 to 1 Apr 2017.
    • 19 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top